Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China flag China · Delayed Price · Currency is CNY
7.82
-0.29 (-3.58%)
Nov 13, 2026, 3:04 PM CST

SHE:300016 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
595.78295.44257.46748.45766.73895.02
Trading Asset Securities
194.38379.75350.77---
Cash & Short-Term Investments
790.16675.18608.23748.45766.73895.02
Cash Growth
13.54%11.01%-18.73%-2.38%-14.33%-11.71%
Accounts Receivable
227.06265.25176.36188.55112.67142.52
Other Receivables
0.638.079.545.878.395.81
Receivables
227.69273.32185.9194.42121.06148.33
Inventory
427.96383.75362.09244.86276.22250.01
Other Current Assets
84.5944.5614.959.071412.72
Total Current Assets
1,5301,3771,1711,1971,1781,306
Property, Plant & Equipment
1,1471,125976.03876.23840.46795.3
Long-Term Investments
585.16576.63536.76556.06561.19553.2
Goodwill
46.9246.9246.92-31.8251.23
Other Intangible Assets
141.57147.22160.82128.39125.1138.99
Long-Term Accounts Receivable
1.351.311.43---
Long-Term Deferred Tax Assets
53.543741.3341.3839.3218.15
Long-Term Deferred Charges
23.925.2724.9417.236.9532.4
Other Long-Term Assets
11.7611.4318.113.385.838.92
Total Assets
3,5413,3482,9782,8192,8192,904

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
222.08214.38171.32115.12140.9141.13
Accrued Expenses
16.6855.0844.534.8932.0526.06
Short-Term Debt
186.19216.96140.02175.56107.6179.08
Current Portion of Long-Term Debt
-37.554912.410.0920.13
Current Portion of Leases
-0.923.263.042.740.27
Current Income Taxes Payable
18.397.84---0.01
Current Unearned Revenue
6.146.668.762.014.453.8
Other Current Liabilities
84.9235.0138.3816.144.8315.09
Total Current Liabilities
534.4574.39455.23359.17302.67285.56
Long-Term Debt
235.58248.79600.24592.55516.28476.1
Long-Term Leases
2.242.164.87.179.980.14
Long-Term Unearned Revenue
19.5924.5216.8411.747.8910.45
Long-Term Deferred Tax Liabilities
88.4980.570.9362.4858.5645.98
Total Liabilities
880.29930.361,1481,033895.39818.22

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
581.69562.87491.95491.93491.96492.72
Additional Paid-In Capital
834.36697.91135.34135.22135.3201.27
Retained Earnings
1,074994.58926.45912.791,0191,042
Treasury Stock
-----0.1-9.06
Comprehensive Income & Other
5.023.36113.86110.67130.27130.04
Total Common Equity
2,4952,2591,6681,6511,7761,857
Minority Interest
166.54158.45161.9135.69146.88229.03
Shareholders' Equity
2,6612,4171,8291,7861,9232,086
Total Liabilities & Equity
3,5413,3482,9782,8192,8192,904

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
424.01506.37797.32790.72646.71575.72
Net Cash (Debt)
366.15168.81-189.09-42.28120.03319.31
Net Cash Growth
79.09%----62.41%2.79%
Net Cash Per Share
0.640.33-0.42-0.090.210.66
Filing Date Shares Outstanding
581.69562.87491.95491.93491.96492.72
Total Common Shares Outstanding
581.69562.87491.95491.93491.96492.72
Working Capital
995.99802.42715.95837.62875.341,021
Book Value Per Share
4.294.013.393.363.613.77
Tangible Book Value
2,3062,0651,4601,5221,6191,667
Tangible Book Value Per Share
3.963.672.973.093.293.38
Buildings
-699.61700.49561.7557.21532.04
Machinery
-609.14567.37503.01470.31400.02
Construction In Progress
-260.8770.26110.3944.9949